Patients with unilateral VS report broadly comparable HRQoL following W&S, SRS, or MS. Although numerical differences in PANQOL scores exist, they are not clinically meaningful. The observed heterogeneity highlights the need for standardized, prospective studies and international collaboration to better inform patient-centered decision-making.
Pruijn et al. (Sun,) studied this question.